GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello A/S (OTCPK:AKBLF) » Definitions » Short-Term Debt

Alk-Abello A/S (Alk-Abello A/S) Short-Term Debt : $2.8 Mil (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Alk-Abello A/S Short-Term Debt?

Alk-Abello A/S's Short-Term Debt for the quarter that ended in Mar. 2024 was $2.8 Mil.

Alk-Abello A/S's quarterly Short-Term Debt increased from Sep. 2023 ($32.1 Mil) to Dec. 2023 ($41.0 Mil) but then declined from Dec. 2023 ($41.0 Mil) to Mar. 2024 ($2.8 Mil).

Alk-Abello A/S's annual Short-Term Debt declined from Dec. 2021 ($37.1 Mil) to Dec. 2022 ($32.2 Mil) but then increased from Dec. 2022 ($32.2 Mil) to Dec. 2023 ($41.0 Mil).


Alk-Abello A/S Short-Term Debt Historical Data

The historical data trend for Alk-Abello A/S's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello A/S Short-Term Debt Chart

Alk-Abello A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.68 2.94 37.08 32.18 40.97

Alk-Abello A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.02 38.56 32.06 40.97 2.77

Alk-Abello A/S Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Alk-Abello A/S Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Alk-Abello A/S's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Alk-Abello A/S (Alk-Abello A/S) Business Description

Traded in Other Exchanges
Address
Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello A/S is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication.

Alk-Abello A/S (Alk-Abello A/S) Headlines

From GuruFocus